GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (NYSE:SYK) » Definitions » Revenue

Stryker (Stryker) Revenue

: $20,498 Mil (TTM As of Dec. 2023)
View and export this data going back to 1988. Start your Free Trial

Stryker's revenue for the three months ended in Dec. 2023 was $5,815 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $20,498 Mil. Stryker's Revenue per Share for the three months ended in Dec. 2023 was $15.16. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $53.42.

Good Sign:

Stryker Corp has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Stryker was 10.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 12.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 8.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Stryker's highest 3-Year average Revenue per Share Growth Rate was 32.90% per year. The lowest was 4.80% per year. And the median was 12.40% per year.


Stryker Revenue Historical Data

The historical data trend for Stryker's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,884.00 14,351.00 17,108.00 18,449.00 20,498.00

Stryker Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,202.00 4,778.00 4,996.00 4,909.00 5,815.00

Competitive Comparison

For the Medical Devices subindustry, Stryker's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stryker Revenue Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's Revenue distribution charts can be found below:

* The bar in red indicates where Stryker's Revenue falls into.



Stryker Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $20,498 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stryker  (NYSE:SYK) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Stryker Revenue Related Terms

Thank you for viewing the detailed overview of Stryker's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Stryker (Stryker) Business Description

Address
2825 Airview Boulevard, Kalamazoo, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Executives
Srikant Datar director ICF INTERNATIONAL, INC., 9300 LEE HIGHWAY, FAIRFAX VA 22031
Berry William E Jr officer: Vice President, Controller 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Kevin Lobo officer: Group Pres., Neurotech & Spine STRYKER, 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Viju Menon officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Allan C. Golston director 2825 AIRVIEW BLVD., KALAMAZOO MI 49002
Ronda E Stryker director 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher officer: VP, Chief Legal Officer 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
James Andrew Pierce officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Glenn S Boehnlein officer: Vice President, CFO 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
M Kathryn Fink officer: VP, Global Human Resources 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Spencer S Stiles officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio director BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Timothy J Scannell officer: Group President 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Roch Doliveux director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Katherine Ann Owen officer: VP 2825 AIRVIEW BLVD., KALAMAZOO MI 49002

Stryker (Stryker) Headlines

From GuruFocus

Stryker Corp Corporate Analyst Meeting Transcript

By GuruFocus Research 01-23-2024

Q4 2022 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2020 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2021 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2021 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2023 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024